A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, Kristy Wang, Alex G. Rittenhouse, Olivia Akinde, Yolanda Eby, Jessica E. Ruff, Joel N. Blankson, Aura T. Abedon, Jennifer L. Alejo, Andrea L. Cox, Justin R. Bailey, Elizabeth A. Thompson, Sabra L. Klein, Daniel Warren, Jacqueline Garonzik‐Wang, Brian J. Boyarsky, Ioannis Sitaras, Andrew Pekosz, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel
Topics & Concepts
MedicineNeutralizationAntibodyNeutralizing antibodyVirologyVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologySpike ProteinPopulationCoronavirus disease 2019 (COVID-19)Internal medicineInfectious disease (medical specialty)DiseaseEnvironmental healthSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing